🐬
|
CTGF and SMADs, Maintenance of Scleroderma Phenotype Is Independent of SMAD Signaling*
Alan Holmes,
David J. Abraham,
S. Sa,
Shiwen Xu,
C. Black,
A. Leask
|
8 |
2001 |
8 🐬
|
🐜
|
Iloprost suppresses connective tissue growth factor production in fibroblasts and in the skin of scleroderma patients.
9 auth.
R. Stratton,
Shiwen Xu,
G. Martini,
A. Holmes,
A. Leask,
Thomas E. Haberberger,
...
G. Martin,
C. Black,
D. Abraham
|
7 |
2001 |
7 🐜
|
🐜
|
Clinical and pathological significance of interleukin 6 overexpression in systemic sclerosis
7 auth.
K. Khan,
Shiwen Xu,
S. Nihtyanova,
E. Derrett-Smith,
D. Abraham,
C. Denton,
...
V. Ong
|
7 |
2012 |
7 🐜
|
🦁
|
Autocrine overexpression of CTGF maintains fibrosis: RDA analysis of fibrosis genes in systemic sclerosis.
11 auth.
Shiwen Xu,
D. Pennington,
A. Holmes,
A. Leask,
D. Bradham,
J. Beauchamp,
...
C. Fonseca,
R. Bois,
G. Martin,
C. Black,
D. Abraham
|
7 |
2000 |
7 🦁
|
🐢
|
Interferon-alpha does not improve outcome at one year in patients with diffuse cutaneous scleroderma: results of a randomized, double-blind, placebo-controlled trial.
8 auth.
C. Black,
A. Silman,
A. Herrick,
C. Denton,
Helen Wilson,
J. Newman,
...
Lucie Pompon,
Shiwen Xu
|
7 |
1999 |
7 🐢
|
🐬
|
Anti-RNA polymerases and other autoantibody specificities in systemic sclerosis.
C. Bunn,
C. Denton,
Shiwen Xu,
C. Knight,
C. Black
|
7 |
1998 |
7 🐬
|
🐜
|
Serial circulating adhesion molecule levels reflect disease severity in systemic sclerosis.
7 auth.
C. Denton,
M. Bickerstaff,
Shiwen Xu,
Mt Carulli,
D. Haskard,
R. Dubois,
...
C. Black
|
7 |
1995 |
7 🐜
|
🐜
|
Therapeutic interleukin-6 blockade reverses transforming growth factor-beta pathway activation in dermal fibroblasts: insights from the faSScinate clinical trial in systemic sclerosis
10 auth.
C. Denton,
V. Ong,
Shiwen Xu,
Haiyin Chen-Harris,
Z. Modrusan,
R. Lafyatis,
...
D. Khanna,
A. Jahreis,
J. Siegel,
T. Sornasse
|
7 |
2018 |
7 🐜
|
🐢
|
Chlorpyrifos induces the apoptosis and necroptosis of L8824 cells through the ROS/PTEN/PI3K/AKT axis.
Lanqiao Wang,
Lan-fang Wang,
Xu Shi,
Shiwen Xu
|
6 |
2020 |
6 🐢
|
🐬
|
The control of ccn2 (ctgf) gene expression in normal and scleroderma fibroblasts
A. Leask,
S. Sa,
A. Holmes,
Shiwen Xu,
C. Black,
D. Abraham
|
6 |
2001 |
6 🐬
|
🐜
|
Epithelial cells promote fibroblast activation via IL-1alpha in systemic sclerosis.
9 auth.
N. Aden,
A. Nuttall,
Shiwen Xu,
P. de Winter,
A. Leask,
C. Black,
...
C. Denton,
D. Abraham,
R. Stratton
|
6 |
2010 |
6 🐜
|